Abstract | OBJECTIVES: State of the art of antithrombotics and their use recommendations during pregnancy. METHODS: A review RESULTS: CONCLUSIONS: During pregnancy, all antithrombotics, except the oral forms, can be used, but the low molecular weight heparins replacing the unfractionated ones in the treatment and prevention of venous thromboembolism remain the treatment of choice.
|
Authors | Céline Chauleur, Jean-Christophe Gris, Pierre Seffert, Patrick Mismetti |
Journal | Therapie
(Therapie)
2011 Sep-Oct
Vol. 66
Issue 5
Pg. 437-43
ISSN: 0040-5957 [Print] France |
Vernacular Title | Mise au point sur les antithrombotiques et la grossesse. |
PMID | 22031688
(Publication Type: English Abstract, Journal Article, Review)
|
Copyright | © 2011 Société Française de Pharmacologie et de Thérapeutique. |
Chemical References |
- Fibrinolytic Agents
- Folic Acid Antagonists
- Vitamin K
- Heparin
- Thrombin
- Factor Xa
- Aspirin
|
Topics |
- Adult
- Aspirin
(administration & dosage, adverse effects, therapeutic use)
- Factor Xa
(adverse effects)
- Female
- Fibrinolytic Agents
(administration & dosage, adverse effects, therapeutic use)
- Folic Acid Antagonists
(adverse effects)
- Heparin
(administration & dosage, adverse effects, therapeutic use)
- Humans
- Pregnancy
- Pregnancy Complications
(drug therapy)
- Pregnancy Trimester, Third
(physiology)
- Thrombin
(antagonists & inhibitors)
- Thrombolytic Therapy
- Venous Thromboembolism
(drug therapy)
- Vitamin K
(antagonists & inhibitors)
|